GlassScriptPhysician profile
Richard Orlowski
NPI 1427053461
$25,531.06
in general payments reported to CMS, 2019-2025
100 companies · $4,066 in 2025
The $4,066 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,784 · 2020: $3,269 · 2021: $4,511 · 2022: $3,788 · 2023: $3,593 · 2024: $3,519 · 2025: $4,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $273 · Long Term Medical Supply Or Device Loan: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,738.71 |
| Education | $272.94 |
| Long Term Medical Supply Or Device Loan | $166.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,215.58 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,708.43 | 2019-2025 | Enhertu, Lynparza, Imfinzi |
| Genentech USA, INC. | $1,349.13 | 2019-2025 | Tecentriq, Venclexta, Gavreto |
| E.R. Squibb & Sons, L.L.C. | $1,263.38 | 2019-2025 | Opdivo, Eliquis, Orencia |
| Merck Sharp & Dohme LLC | $1,254.47 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $1,085.01 | 2019-2025 | |
| Janssen Biotech, INC. | $974.34 | 2019-2025 | Tecvayli, Darzalex, Erleada |
| Daiichi Sankyo INC. | $929.61 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $896.22 | 2019-2025 | Jakafi, Niktimvo, Monjuvi |
| Eisai INC. | $822.78 | 2019-2025 | |
| Genzyme Corporation | $815.86 | 2019-2025 | |
| Exelixis INC. | $662.46 | 2019-2025 | Cabometyx |
| Amgen INC. | $604.02 | 2019-2023 | Kyprolis, Blincyto, Nplate |
| Bayer Healthcare Pharmaceuticals INC. | $511.40 | 2019-2025 | |
| Celgene Corporation | $499.10 | 2019-2024 | Reblozyl, Pomalyst, Opdualag |
Show all 100 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $483.82 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Seagen INC. | $454.84 | 2019-2023 | Tukysa, Padcev, Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $418.28 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Puma Biotechnology, INC. | $342.37 | 2020-2025 | |
| Lilly USA, LLC | $305.02 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Karyopharm Therapeutics INC. | $304.74 | 2020-2025 | Xpovio |
| Array Biopharma INC | $293.18 | 2019-2025 | Braftovi, Lorbrena, Mektovi |
| Abbvie INC. | $279.08 | 2019-2025 | |
| Astellas Pharma US INC | $256.39 | 2019-2025 | Vyloy, Padcev, Xospata |
| Pharmacyclics LLC, An Abbvie Company | $252.30 | 2019-2023 | Imbruvica, Epkinly |
| Emd Serono, INC. | $251.91 | 2019-2025 | Bavencio, Tepmetko |
| Gilead Sciences, INC. | $240.54 | 2020-2025 | Trodelvy |
| Aveo Pharmaceuticals, INC. | $233.22 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $225.77 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $222.30 | 2019-2025 | Libtayo, Lynozyfic |
| Servier Pharmaceuticals LLC | $201.25 | 2021-2025 | |
| Acrotech Biopharma INC. | $199.19 | 2021-2025 | Beleodaq |
| Alexion Pharmaceuticals, INC. | $196.84 | 2019-2025 | Ultomiris |
| Beigene USA, INC. | $186.98 | 2020-2024 | Brukinsa, Tevimbra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.37 | 2020-2023 | Gilotrif |
| Taiho Oncology, INC. | $178.00 | 2019-2025 | |
| Novocure INC. | $139.65 | 2019-2022 | |
| Genmab U.S., INC. | $121.62 | 2023-2024 | Tivdak, Epkinly |
| Pharmaessentia USA Corporation | $115.19 | 2022-2025 | Besremi |
| Beone Medicines USA, INC. | $104.16 | 2025 | Brukinsa, Tevimbra |
| Ipsen Biopharmaceuticals, INC | $99.57 | 2019-2025 | Onivyde, Somatuline Depot |
| Dova Pharmaceuticals | $97.81 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $96.00 | 2023 | |
| Coherus Oncology, INC. | $90.26 | 2021-2024 | |
| Clovis Oncology, INC. | $88.73 | 2019-2021 | |
| Mirati Therapeutics, INC. | $88.57 | 2023-2024 | Krazati |
| Epizyme, INC. | $85.42 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $81.39 | 2021-2024 | Precisetumor, Myrisk |
| Octapharma USA, INC. | $76.77 | 2020 | |
| Deciphera Pharmaceuticals INC. | $74.74 | 2020-2025 | |
| Adaptive Biotechnologies Corporation | $71.45 | 2023-2025 | Clonoseq |
| Foundation Medicine, INC. | $69.80 | 2020-2023 | |
| Kite Pharma, INC. | $69.55 | 2022-2025 | Yescarta |
| Sobi, INC | $66.98 | 2022-2024 | |
| Pharmacosmos Therapeutics INC. | $63.90 | 2020-2025 | Monoferric |
| Mylan Institutional INC. | $60.91 | 2019-2020 | |
| Adc Therapeutics America, INC. | $60.66 | 2022-2025 | |
| Tg Therapeutics, INC. | $57.70 | 2021-2022 | |
| Verastem, INC. | $55.13 | 2019 | |
| Spectrum Pharmaceuticals INC. | $54.22 | 2023-2025 | Rolvedon |
| Eusa Pharma (US) LLC | $54.16 | 2020-2022 | |
| Heron Therapeutics, INC. | $52.93 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $52.22 | 2022-2023 | Yonsa, Odomzo |
| Caris Mpi, INC. | $49.32 | 2025 | Mi Cancer Seek |
| G1 Therapeutics, INC. | $46.39 | 2022 | |
| Secura Bio, INC. | $44.80 | 2020-2021 | |
| Inari Medical, INC. | $44.60 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Rigel Pharmaceuticals, INC. | $41.55 | 2020-2025 | Gavreto, Rezlidhia, Tavalisse |
| Teva Pharmaceuticals USA, INC. | $39.61 | 2020-2021 | |
| Agios Pharmaceuticals, INC. | $36.52 | 2020 | |
| Tersera Therapeutics LLC | $36.46 | 2020-2022 | |
| Cycle Pharmaceuticals INC | $35.92 | 2025 | Phyrago |
| Springworks Therapeutics, INC. | $35.16 | 2024-2025 | Ogsiveo |
| Azurity Pharmaceuticals, INC. | $33.77 | 2024-2025 | Vivimusta, Danziten |
| Avyxa Pharma, LLC | $33.59 | 2024 | |
| Amneal Pharmaceuticals LLC | $33.09 | 2023-2025 | Avastin, Alymsys |
| Apellis Pharmaceuticals, INC. | $32.87 | 2025 | Empaveli |
| Biocon Biologics INC | $31.07 | 2025 | Ogivri |
| Tesaro, INC. | $30.81 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $29.93 | 2019 | |
| Tempus Ai, INC | $29.90 | 2025 | Xt Cdx |
| Global Blood Therapeutics, INC. | $27.51 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $27.01 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $26.83 | 2021 | |
| Iovance Biotherapeutics, INC. | $26.53 | 2025 | Amtagvi |
| Fresenius Kabi USA, LLC | $26.28 | 2024 | Stimufend |
| Geron Corporation | $25.80 | 2025 | Rytelo |
| Janssen Scientific Affairs, LLC | $24.49 | 2019 | |
| Kyowa Kirin, INC. | $24.43 | 2019-2021 | |
| Morphosys, US INC. | $23.66 | 2021 | |
| Organon LLC | $23.10 | 2022-2023 | Ontruzant |
| Stemline Therapeutics INC. | $19.49 | 2023 | Orserdu |
| Celltrion USA INC. | $18.57 | 2024 | Vegzelma |
| Alnylam Pharmaceuticals INC. | $17.55 | 2025 | Givlaari |
| Acceleron Pharma, INC. | $16.99 | 2021 | |
| Medtronic, INC. | $16.62 | 2023 | Osteocool Rf Ablation System |
| Recordati_rare_diseases_inc. | $15.73 | 2025 | Enjaymo |
| Immunocore Limited | $15.45 | 2025 | Kimmtrak |
| Aurobindo Pharma USA, INC. | $14.23 | 2020 | |
| Nestle Healthcare Nutrition INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
Keytruda $568Enhertu $489Lynparza $429Opdivo $406Lenvima $372Kisqali $304Nubeqa $280Jakafi $276Pluvicto $211Xofigo $209Tecentriq $206Cabometyx $204Venclexta $193Fotivda $187Adcetris $182Tecvayli $176Xtandi $170Xpovio $165Braftovi $162Elrexfio $160Padcev $160Lorbrena $150Verzenio $146Jaypirca $146Darzalex $145Bosulif $144Gavreto $144Talzenna $143Beleodaq $139Ojjaara $139Tukysa $139Ibrance $135Brukinsa $134Injectafer $132Reblozyl $132Imfinzi $131Alecensa $129Rozlytrek $129Sarclisa $127Avastin $126Zejula $125Jemperli $123Imbruvica $123Erleada $120Elitek $119Orgovyx $113Fabhalta $107Mektovi $106Libtayo $104Ultomiris $103Tagrisso $103Lutathera $102Eliquis $101Vitrakvi $101Tibsovo $97.17Besremi $92.40Trodelvy $89.76Krazati $88.57Jevtana $88.25Retevmo $88.19Ninlaro $87.71Inlyta $86.42Calquence $81.79Paxlovid $80.31Akeega $79.87Stivarga $74.05Tivdak $73.16Comirnaty $71.45Clonoseq $71.45Epkinly $70.66Welireg $69.51Lonsurf $69.49Onivyde $68.97Datroway $68.37Bavencio $64.65Talvey $64.57Niktimvo $56.16Nerlynx $55.37Rolvedon $54.22Fruzaqla $53.51Piqray $53.10Pomalyst $51.21Inqovi $51.11Opdualag $50.52Somatuline Depot $49.56Mi Cancer Seek $49.32Gilotrif $48.63Scemblix $47.56Blenrep $47.21Yescarta $46.62Kyprolis $44.99Alunbrig $44.71Rybrevant $43.43Monoferric $42.09Balversa $40.56Polivy $40.11Lunsumio $40.11Ziihera $39.36Tevimbra $37.82Phyrago $35.92
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Orlowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.